Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production.

Cell Reports
Valentin SencioFrançois Trottein

Abstract

Secondary bacterial infections often complicate viral respiratory infections. We hypothesize that perturbation of the gut microbiota during influenza A virus (IAV) infection might favor respiratory bacterial superinfection. Sublethal infection with influenza transiently alters the composition and fermentative activity of the gut microbiota in mice. These changes are attributed in part to reduced food consumption. Fecal transfer experiments demonstrate that the IAV-conditioned microbiota compromises lung defenses against pneumococcal infection. In mechanistic terms, reduced production of the predominant short-chain fatty acid (SCFA) acetate affects the bactericidal activity of alveolar macrophages. Following treatment with acetate, mice colonized with the IAV-conditioned microbiota display reduced bacterial loads. In the context of influenza infection, acetate supplementation reduces, in a free fatty acid receptor 2 (FFAR2)-dependent manner, local and systemic bacterial loads. This translates into reduced lung pathology and improved survival rates of double-infected mice. Lastly, pharmacological activation of the SCFA receptor FFAR2 during influenza reduces bacterial superinfection.

Citations

Jun 5, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Silan GuLanjuan Li
Jun 24, 2020·Frontiers in Public Health·David BaudEric Giannoni
Jun 17, 2020·Critical Reviews in Food Science and Nutrition·Ricardo Wesley AlbercaMaria Notomi Sato
Sep 18, 2020·European Journal of Clinical Nutrition·Ronan ThibaultPierre Déchelotte
Aug 30, 2020·Pathogens and Disease·Vadim MakarovSergei Chepur
Nov 28, 2020·Microbial Cell Factories·Taha BaghbaniHamed Haddad Kashani
Nov 11, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Eliza M MeloMauro M Teixeira
Jan 27, 2021·Trends in Pharmacological Sciences·Graeme MilliganAndrew B Tobin
Jan 27, 2021·Acta Pharmacologica Sinica·Jian-Jian JiZhi-Gang Lu
Feb 2, 2021·Science China. Life Sciences·Jia LuoFeng Jin
Feb 14, 2021·International Journal of Molecular Sciences·Manuel GrundmannFrank Eitner
Dec 17, 2020·Frontiers in Cellular and Infection Microbiology·Sabrina Donati ZeppaPiero Sestili
Feb 11, 2021·Immunity·Andrea C Wong, Maayan Levy
Nov 17, 2020·Frontiers in Pediatrics·Kun Yang, Wenbin Dong
Jan 26, 2021·Clinical & Translational Immunology·Yu Anne YapEliana Mariño
Dec 16, 2020·Ageing Research Reviews·Vinciane Saint-CriqMuriel Thomas
Feb 23, 2021·Frontiers in Immunology·Deepak SumbriaBarry T Rouse
Aug 25, 2020·Current Opinion in Endocrine and Metabolic Research·Daniele BologniniGraeme Milligan
Feb 22, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Farhan CyprianMaha Al-Asmakh
Mar 30, 2021·Interdisciplinary Perspectives on Infectious Diseases·Imane AllaliHassan Ghazal
Mar 31, 2021·Advances in Nutrition·Laurence DaoustAndré Marette
Nov 3, 2020·Virus Research·Faizan Ahmed Sadiq
Apr 15, 2021·Cellular & Molecular Immunology·Chang H Kim
Apr 13, 2021·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Amin GasmiGeir Bjørklund
Jun 1, 2021·Food Science and Biotechnology·Na-Kyoung Lee, Hyun-Dong Paik
May 20, 2021·MBio·Hannah M Rowe, Jason W Rosch
May 18, 2021·Current Opinion in Virology·Vu L Ngo, Andrew T Gewirtz
Jun 6, 2021·The Journal of Nutritional Biochemistry·Paula R AugustiTatiana Emanuelli
Jun 8, 2021·Infection and Immunity·Marina Gomes MachadoFrançois Trottein
Dec 18, 2020·The Journal of Infectious Diseases·Andrew NishimotoHannah M Rowe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Related Papers

Scandinavian Journal of Infectious Diseases
C Jarstrand, G Tunevall
BioRxiv : the Preprint Server for Biology
Helen T GrovesJohn S Tregoning
The Journal of Immunology : Official Journal of the American Association of Immunologists
Caleb C J ZavitzMartin R Stampfli
© 2021 Meta ULC. All rights reserved